Dr. Geetha B. Kandimala, MD
Neurology (Clinical Neurophysiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 974
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Neurophysiology Physician primary
OK license 26013 -
Neurology Physician
OK license 26013 -
Sleep Medicine (Psychiatry & Neurology) Physician
OK license 26013
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norman Regional Norman, OK
- Memorial Health Lawton, OK
- Duncan Regional Hospital, Inc Duncan, OK
- Southwestern Medical Center Lawton, OK
Medical groups
- Norman Regional Providers Specialty Care (142 clinicians)
- Rocky Mountain Sleep Disorders Center Inc (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 974
- Services billed
- 8,994
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,101 | 685 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 288 | 155 |
| New patient office or other outpatient visit, 45-59 minutes | 180 | 180 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 120 | 120 |
| Established patient office or other outpatient visit, 20-29 minutes | 119 | 100 |
| Established patient office or other outpatient visit, 40-54 minutes | 91 | 83 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 60 | 30 |
| Nerve conduction, 11-12 studies | 60 | 60 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 55 | 54 |
| Nerve conduction, 9-10 studies | 30 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Norman, OK | 413 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Norman, OK | 410 |
| Topiramate Other prescribers in Norman, OK | 336 |
| Memantine Hcl Other prescribers in Norman, OK | 262 |
| Donepezil Hcl Other prescribers in Norman, OK | 262 |
| Levetiracetam Other prescribers in Norman, OK | 218 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Norman, OK | 213 |
| Lacosamide Other prescribers in Norman, OK | 185 |
| Lamotrigine Other prescribers in Norman, OK | 181 |
| Ropinirole Hcl Other prescribers in Norman, OK | 162 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 26 companies reported 191 payments worth $4,646 in total to this clinician.
| AbbVie Inc. | $986 |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $494 |
| Argenx US, Inc. | $369 |
| Lundbeck LLC | $320 |
| Neurocrine Biosciences, Inc. | $311 |
| UCB, Inc. | $276 |
| Sk Life Science, Inc. | $232 |
| Pfizer Inc. | $221 |
| Food and Beverage | $4,564 |
|---|---|
| Education | $81.49 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. Aug 13, 2025 | Education in-kind | $81.49 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.